The election of endothelial progenitor cells as vehicle for the delivery of eNOS lies in the fact that this type of cells are bone marrow-derived cells that favor endothelial hemostasis and angiogenesis after an insult, and they have rendered positive results in experimental models of PAH [105]. Here, NOS3 is linked to pulmonary arterial hypertension.